Physician profile
Patrick Felton
NPI 1679519672
$1,658.92
in general payments reported to CMS, 2019-2025
14 companies · $267 in 2025
The $267 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $97.33 · 2021: $43.56 · 2022: $34.25 · 2023: $1,004 · 2024: $213 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $856 · Food and Beverage: $627.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $856.44 |
| Food and Beverage | $627.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $462.48 | 2023 | |
| Supreme Orthopedic Systems, LLC | $431.96 | 2023 | |
| Organogenesis INC. | $163.83 | 2020-2024 | Affinity |
| Medtronic, INC. | $150.00 | 2025 | Venaseal |
| Stryker Corporation | $107.29 | 2024-2025 | Prostep Mica, Augment Injectable |
| Bard Peripheral Vascular, INC. | $72.56 | 2025 | Rotarexs 6 F X 135 Cm |
| Smith+Nephew, INC. | $72.35 | 2022-2024 | Collagenase Santyl |
| Integra Lifesciences Corporation | $43.19 | 2020-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Horizon Therapeutics Plc | $35.30 | 2022-2023 | Krystexxa |
| Abbvie INC. | $33.68 | 2023 | |
| Linvatec Corporation | $28.13 | 2021 | |
| Convatec INC. | $22.65 | 2024 | |
| Abbott Laboratories | $18.96 | 2023 | Proclaim |
| Kerecis Limited | $16.54 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Felton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.